The proportion of patients who experienced MG-related hospitalization or ER visit was significantly higher in the titin+ group (82.8 and 55.2%, respectively) than in the titin– group (48.3 and 20.7%, p = 0.006 and p = 0.007, respectively). The gene discussed is TTN; the disease is myasthenia gravis.